Symbol
Taysha Gene Therapies, Inc.
Full name of the company.
MEDICAL-GENERIC DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.26
Current price of the stock
$3M
Trading volume of the stock
$337.5M
Market capitalization of the company
Small Cap
Category of market capitalization
-
Long-term growth mean estimate
4.90
Mean analyst rating
419.84%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.48
Total debt to total equity ratio
5.51
Current ratio
100.00%
Gross profit margin
-1448.43%
Operating profit margin
-1448.43%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1427.52%
Pretax profit margin
-1427.52%
Net profit margin
-28.74%
Measures profitability relative to shareholders' equity
-28.74%
ROE excluding intangible assets
-14.16%
Measures profitability relative to total assets
-19.37%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
3.71
Measures valuation relative to earnings
-
P/E based on future earnings estimates
34.04
Measures valuation relative to sales
2.91
Measures valuation relative to book value
-1.12
Measures valuation relative to operating cash flow
-1.08
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
